Document is current
Any future updates will be listed below
-
Authors
Heckmann, Markus B.
Münster, Jan P.
Finke, Daniel
Hund, Hauke
Schunn, Fabian
Debus, Jürgen
Mages, Christine
Frey, Norbert
Rahm, Ann-Kathrin
Lehmann, Lorenz H.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 21 October 2024
First Online: 14 November 2024
Declarations
:
: The study protocol was approved by the ethics committees of the Medical Faculty of the University Heidelberg (S-240/2017).
: D.F., J.M., N.F., J.D., H.H., F.S. declare no conflict of interest. L.H. has served on the advisory board for Daiichi Sankyio, Senaca, Astra Zeneca and Servier, as an external expert for Astra Zeneca and received speakers’ honoraria from Novartis and MSD. M.H. received speakers’ honaria from Bristol Myers Squibb and Daiichi Sankyo. C. M. acknowledges educational support from Biotronik and Johnson & Johnson. A.K.R received educational support from Boston Scientific, Medtronic, Abbott and BiosenceWebster. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
